Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A.

Abstract

BACKGROUND:

Low plasma levels of high-density lipoprotein-cholesterol (HDL-C) are typical of acute myocardial infarction (MI) and predict risk of recurrent cardiovascular events. The potential relationships between modifications in the molecular composition and the functionality of HDL subpopulations in acute MI however remain indeterminate.

METHODS AND RESULTS:

ST segment elevation MI (STEMI) patients were recruited within 24h after diagnosis (n=16) and featured low HDL-C (-31%, p<0.05) and acute-phase inflammation (determined as marked elevations in C-reactive protein, serum amyloid A (SAA) and interleukin-6) as compared to age- and sex-matched controls (n=10). STEMI plasma HDL and its subpopulations (HDL2b, 2a, 3a, 3b, 3c) displayed attenuated cholesterol efflux capacity from THP-1 cells (up to -32%, p<0.01, on a unit phospholipid mass basis) vs.

CONTROLS:

Plasma HDL and small, dense HDL3b and 3c subpopulations from STEMI patients exhibited reduced anti-oxidative activity (up to -68%, p<0.05, on a unit HDL mass basis). HDL subpopulations in STEMI were enriched in two proinflammatory bioactive lipids, lysophosphatidylcholine (up to 3.0-fold, p<0.05) and phosphatidic acid (up to 8.4-fold, p<0.05), depleted in apolipoprotein A-I (up to -23%, p<0.05) and enriched in SAA (up to +10.2-fold, p<0.05); such changes were most marked in the HDL3b subfraction. In vitro HDL enrichment in both lysophosphatidylcholine and phosphatidic acid exerted deleterious effects on HDL functionality.

CONCLUSIONS:

In the early phase of STEMI, HDL particle subpopulations display marked, concomitant alterations in both lipidome and proteome which are implicated in impaired HDL functionality. Such modifications may act synergistically to confer novel deleterious biological activities to STEMI HDL.

SIGNIFICANCE:

Our present data highlight complex changes in the molecular composition and functionality of HDL particle subpopulations in the acute phase of STEMI, and for the first time, reveal that concomitant modifications in both the lipidome and proteome contribute to functional deficiencies in cholesterol efflux and antioxidative activities of HDL particles. These findings may provide new biomarkers and new insights in therapeutic strategy to reduce cardiovascular risk in this clinical setting where such net deficiency in HDL function, multiplied by low circulating HDL concentrations, can be expected to contribute to accelerated atherogenesis.

• Authors: Fabiana Rached, Marie Lhomme, Laurent Camont, Fernando Gomes, Carolane Dauteuille, Paul Robillard, Raul D Santos, Philippe Lesnik, Carlos V Serrano Jr, M John Chapman, Anatol Kontush
• Journal: Biochimica et biophysica acta (Biochim Biophys Acta) Vol. 1851 Issue 9 Pg. 1254-61 (Sep 2015) ISSN: 0006-3002 [Print] Netherlands
• PMID: 26037829 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2015 Elsevier B.V. All rights reserved.

Chemical References

• Apolipoprotein A-I
• IL6 protein, human
• Interleukin-6
• Lipoproteins, HDL3
• Lysophosphatidylcholines
• Phosphatidic Acids
• Proteome
• Serum Amyloid A Protein
• C-Reactive Protein

Topics

• Adult
• Aged
• Apolipoprotein A-I (chemistry, deficiency, metabolism)
• C-Reactive Protein (metabolism)
• Case-Control Studies
• Cell Line
• Female
• Humans
• Interleukin-6 (blood)
• Lipoproteins, HDL3 (blood, chemistry)
• Lysophosphatidylcholines (blood, chemistry)
• Male
• Middle Aged
• Monocytes (metabolism)
• Myocardial Infarction (blood, pathology)
• Phosphatidic Acids (blood, chemistry)
• Proteome (chemistry, metabolism)
• Serum Amyloid A Protein (metabolism)